News
Malaria pill trialed to prevent COVID-19
A trial to see whether two anti-malarial drugs could prevent COVID-19 has begun in Brighton and Oxford.
Chloroquine, hydroxychloroquine or a placebo will be given to more than 40,000 healthcare workers from Europe, Africa, Asia and South America.
All the participants are staff who are in contact with COVID-19 patients.
US President Donald Trump was criticised this week after he said he had been taking hydroxychloroquine, despite warnings it might be unsafe.
The first UK participants in the global trial were enrolled yesterday at the Brighton and Sussex University Hospitals and the John Radcliffe Hospital in Oxford.
They will be given either hydroxychloroquine or a placebo for three months. At sites in Asia, participants will be given chloroquine or a placebo.
These are the first of a planned 25 UK sites, with results expected by the end of the year.
The trial is open to anyone delivering direct care to coronavirus patients in the UK, as long as they have not been diagnosed with COVID-19.
It will test whether the drugs can prevent healthcare workers exposed to the virus from contracting it.
One of the study’s leaders, Prof Nicholas White at the University of Oxford said: “We really do not know if chloroquine or hydroxychloroquine are beneficial or harmful against COVID-19.”
But, he said, a randomised controlled trial such as this one, where neither the participant nor the researchers know who has been given the drug or a placebo, was the best way to find out.
“A widely available, safe and effective vaccine may be a long way off,” said Prof Martin Llewelyn from Brighton and Sussex Medical School, who is also leading the study.
“If drugs as well-tolerated as chloroquine and hydroxychloroquine could reduce the chances of catching COVID-19, this would be incredibly valuable.”
The drugs can reduce fever and inflammation and are used as both a prevention and a treatment for malaria.
Hydroxychloroquine regulates the body’s immune response and is also used in the treatment of rheumatoid arthritis and Lupus – an inflammatory disease caused by an overactive immune system.
Lupus charities in the UK and US have raised concerns that demand for the drug associated with coronavirus could threaten the supply for patients who already rely on it. -BBC
Local mattress manufacturers have raised serious concerns over the influx of substandard mattresses, warning that these products pose significant health risks to consumers and threaten the sustainability of Ghana’s mattress industry.
At a press briefing held in Kumasi on Tuesday, manufacturers accused unregistered foreign entities, particularly Chinese firms, of flooding the market with cheap mattresses made from polystyrene.
Mr Yaw Ampem Darko, a spokesperson for the local manufacturers, warned that prolonged use of substandard mattresses, especially those made with polystyrene, could result in chronic back pain, musculoskeletal disorders, poor posture, and diminished sleep quality.
These health implications, they stressed, were not always immediately evident but accumulate over time, especially among vulnerable populations such as children and the elderly.
This material, typically used for packaging, is considered unsuitable and unsafe for bedding.
According to industry leaders, these sub-standard products have been circulating for at least five years, gaining traction among unsuspecting consumers due to their unusually low prices.
“These mattresses are being sold at suspiciously low prices, luring unsuspecting consumers who are unaware of the health dangers.”
“We are not just protecting our businesses; we are protecting Ghanaian lives. The government must act swiftly to stem this tide before more citizens fall victim to these dangerous products,” Mr Yaw Ampem Darko stated.
The Ghana Standards Authority (GSA) has acknowledged the issue and, in response, announced a nationwide enforcement campaign aimed at clamping down on the production, distribution, and sale of substandard mattresses.
The campaign, which was scheduled to take effect from September 30, 2025, was empowered by the GSA Act, 2022 (Act 1078), which authorises the Authority to seize and seal non-compliant products and impose sanctions on offenders.
In a statement signed by the Director General of the GSA, Professor George Agyei, the authority cited Sections 29 and 43 of the Act, reiterating that all mattresses sold in Ghana must meet established national standards or face confiscation.
The statement further emphasised that mattresses failing to meet these standards not only compromise sleep quality but also contribute to long-term health complications, including spinal and neck pain.
Despite the GSA’s commitment, manufacturers have expressed frustration over delays in implementation and called for stronger enforcement mechanisms.
They urged the GSA to work in close collaboration with the Customs Division of the Ghana Revenue Authority and national law enforcement agencies to identify and prosecute violators of Ghana’s quality standards.
Manufacturers are also appealing to consumers to remain vigilant and prioritise their health by verifying that any mattress they purchase bears the GSA certification mark.
Moreover, they caution the public against purchasing suspiciously cheap mattresses that lack proper labelling or identifiable branding, as these were often indicators of substandard or counterfeit products.
As the official enforcement deadline had expired with no show, the local producers insisted that much more than business interests were at stake.
They argued that without swift and sustained action, the health and safety of Ghanaian consumers would continue to be compromised.
“Public awareness, strict enforcement, and collaboration among regulatory bodies are essential if we are to protect the integrity of the local industry and the wellbeing of the Ghanaian people,” Mr Darko indicated.
From Kingsley E. Hope, Kumasi
Join our WhatsApp Channel now!
https://whatsapp.com/channel/0029VbBElzjInlqHhl1aTU27
The Founder of the Raissa Child Protection Initiative, Ms Raissa Sambou, has urged authorities to impose severe punishment on individuals, including teachers and guardians, who sexually abuse young girls.
Speaking in an interview to mark this year’s International Day of the Girl Child (October 11), Ms Sambou condemned the increasing cases of sexual exploitation involving minors, describing such acts as “heartless, criminal, and a total betrayal of trust.”
She noted that those entrusted with the care and education of children must not be the same people who violate them, stressing that “anyone found guilty of abusing a girl child must face the full rigours of the law without leniency.”
The International Day of the Girl Child is observed annually to promote the rights of girls, empower them to reach their full potential, and draw attention to the challenges they face worldwide.
Ms Sambou lamented that poverty continues to push many young girls into vulnerable situations, exposing them to exploitation.
She expressed concern that some headmasters, teachers, and community members who should protect girls rather take advantage of them.
“This must stop immediately. The safety of every girl must never be compromised,” she said, urging the public to report all forms of abuse to the appropriate authorities and called for swift action by law enforcement agencies against perpetrators.
Addressing girls directly, Ms Sambou encouraged them to take their education seriously and to believe in their potential.
“It is possible to be young and responsible. Your future is bright, protect it, believe in it, and never let anyone dim your light,” she advised.
She further urged girls to choose their friends wisely, stay disciplined, and speak up if anyone makes sexual advances toward them.
Ms Sambou concluded with a rallying call for collective action, saying “speak up, protect them, and empower them. Together, we can end the sexual exploitation of girls.”
By Esinam Jemima Kuatsinu
Join our WhatsApp Channel now!
https://whatsapp.com/channel/0029VbBElzjInlqHhl1aTU27
